This year’s joint ECTRIMS-ACTRIMS congress was held on October 11-13 in Milan, Italy. Click here for the Daily Highlights. Read More
Latest News
ECTRIMS-ACTRIMS 2023 survey
September 20, 2023Help make the NeuroSens coverage of MSMilan 2023 (The 9th Joint ECTRIMS-ACTRIMS Meeting) relevant to you.
Complete the survey below to tell us what topics are of greatest interest to you. Read More
K-index a predictor of T2 lesions in CIS, RIS
September 14, 2023A new study has reported that the kappa free light chain index (K-index) can predict the occurrence of new T2 lesions in subjects with clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) (Levraut et al. Neurol Neuroimmunol Neuroinflamm 2023;10:e200156). The K-index was also useful to predict clinical events in CIS. Read More
TERIS trial: final results
September 7, 2023The TERIS trial of teriflunomide in individuals with radiologically isolated syndrome (RIS) has reported that treatment significantly prolonged the time to a first clinical event by 63% versus placebo (Lebrun-Frenay et al. JAMA Neurol, epublished August 21, 2023). Read More